1322 Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in elderly patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. (September 2015) - Kienle, D.; Winterhalder, R.; Koeberle, D.; Horber, D.; Kueng, M.; Saletti, P.; Helbling, D.; Bastian, S.; Dietrich, D.; Baertschi, D.; Pilop, C.; Von Moos, R.